Canada

Search form

Aptima® Herpes Simplex Viruses 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2.1 Differentiating between HSV types 1 and 2 is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2 NAAT testing is increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.1 The Aptima® HSV 1 & 2 assay is a NAAT that distinguishes between HSV-1 and HSV-2 and gives healthcare providers the specific knowledge required to manage patient care.3

References

1. World Health Organization. Herpes simplex virus. http://www.who.int/mediacentre/factsheets/fs400/en/. Published January 2016. Accessed  January 8, 2019.  2. CDC. 2015 Sexually Transmitted Diseases Treatment Guidelines. https://www.cdc.gov/std/tg2015/. Updated January 25, 2017. Accessed January 8, 2019.  3. Aptima HSV 1 & 2 assay [package insert]. AW-15735-001, Rev. 003. San Diego, CA: Hologic, Inc.; 2018.